MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why GRDX Stock dropped -5.38% Today — RQD Quant Desk Flash
$5.45 -5.38% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $5.39
GridAI Technologies Corp. (GRDX) carries a Roarable Rating of E (Strong Sell) with 26/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $38.9M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $5.39 (-1.16%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (26/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-10.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-14.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for GRDX)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (26/100 Composite)
🔍 WHY GRDX SCORES 26/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (31% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
▲ #2 Bullish Driver: Cash Engine Quality+6/20 pts (23% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 0% Gross Margin
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$4.97-15.1% Next Q
18
Q2 (-2Q)Grade E$4.22+32.9% Next Q
21
Q3 (-1Q)Grade E$5.61-2.9% Next Q
23
CurrentGrade E$5.45-10.5% Hist 90D α
26
Trajectory: E (18) → E (26)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a GRDX Turnaround Squeeze
While GRDX currently carries a cautious 26/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.00) and Max Pain ($5.72) forces dealer call-delta covering toward $7.28.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $GRDX• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “GRDX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why GRDX Stock dropped -5.38% Today — RQD Quant Desk Flash
GridAI Technologies Corp. (GRDX) dropped -5.38% to $5.45, trading at 71% of its 52-week range ($1.87 – $6.93). Stretched risk/reward at current multiples (-20% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 71% of its 52-week range ($1.87 – $6.93) with RSI-14 at 54.5 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $5.45 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 0% gross margin and $0 annual free cash flow.
Live GRDX Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring GRDX)
- ✓Walkthrough of GRDX's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
GRDX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +117.13%▲ ASCENDING CHANNEL
2026-10-30O $5.33H $5.84L $4.70C $5.45VOL 147.1K
RES: $6.07SUP: $2.94SMA50: $4.00SMA200: $3.52
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
GRDX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on GRDX today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for GRDX. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for GRDX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (GRDX)
Health Care Rank #987 of 1016
⚔️ SCYX vs GRDX Full Matrix →
1. Head-to-Head Health Care Peer Comparison (GRDX vs. SCYX, VERU, ALDX, NSRX)
Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, GridAI Technologies Corp. (GRDX) ranks #987 by composite RQD confidence (26/100, grade E) and #778 by equity capitalization ($38.9M). Within this direct 5-issuer industry benchmark cohort, GRDX leads on earnings valuation at N/A trailing P/E, while GRDX leads on capital efficiency and profitability with -20.0% ROIC and -30.0% gross margin. ALDX currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with GRDX at 26/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| GRDX
ACTIVE
GridAI Technologies Corp. | E | 26/100 | — | -30.0% | -20.0% | -5.38% | $38.9M | Benchmark Subject |
| SCYX SCYNEXIS Inc. | E | 34/100 | — | — | -35.0% | -2.28% | $38.4M | /scyx-vs-grdx → |
| VERU Veru Inc. | D- | 43/100 | — | — | -35.0% | -1.76% | $38.0M | /veru-vs-grdx → |
| ALDX Aldeyra Therapeutics Inc. | D | 50/100 | — | — | -35.0% | -3.58% | $39.8M | /aldx-vs-grdx → |
| NSRX Nasus Pharma Ltd. | D- | 36/100 | — | — | -35.0% | -4.49% | $37.4M | /nsrx-vs-grdx → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001604191In its most recent audited fiscal period (FY2025, filed 2025-12-31), GridAI Technologies Corp. (GRDX) reported GAAP revenue of $36.3K (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$6.4M, operating cash flow of -$5.7M, and free cash flow of -$5.7M (+38.1% YoY). On the balance sheet, GRDX closed FY2025 with $48.6M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $36.3K | -$6.4M | -$5.7M | -$5.7M | $48.6M | — |
| FY2024 (FY) | 2024-12-31 | $0 | -$18.1M | -$9.2M | -$9.2M | $85.4M | — |
| FY2023 (FY) | 2023-12-31 | $0 | -$15.8M | -$12.4M | -$12.4M | — | — |
3. GRDX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs GRDX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, GridAI Technologies Corp. (NASDAQ: GRDX) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 26/100 at a spot price of $5.45 (-5.38% 1D, market cap $38.9M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, GRDX ranks #987 in composite RQD confidence.
How does GRDX compare to SCYX and VERU in the Health Care sector?
Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), GRDX carries a Roarable E (26/100 RQD), trailing P/E of N/A, gross margin of -30.0%, and ROIC of -20.0%. By comparison, SCYX (SCYNEXIS Inc.) holds a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $38.4M) and VERU (Veru Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $38.0M). Among the 5-stock peer group, GRDX leads on earnings multiple (N/A) while GRDX leads on capital efficiency (-20.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for GRDX?
Per GRDX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001604191), GridAI Technologies Corp. generated $36.3K in revenue, -$6.4M in net income, and -$5.7M in free cash flow against $48.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is GRDX trading relative to its 50-day, 200-day, and 52-week technical levels?
GRDX last traded at $5.45 (-5.38% on volume of 204,135 shares), positioning the stock +36.25% above its 50-day simple moving average ($4.00) and +54.83% above its 200-day simple moving average ($3.52). Across its 52-week range of $1.87 to $6.93, GRDX sits at the 70.8% percentile with a 14-day RSI of 54.5 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.77 to $6.13).
GRDX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is GRDX stock moving today?
Why GRDX Stock dropped -5.38% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-20% return on capital) under elevated 10-year interest-rate pressure.